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Abstract
Background: Wound infections are associated with increased morbidity and mortality.
Objectives: To determine the prevalence, aetiology and susceptibility profile of  bacterial agents of  wound infection among
in- and- out patients at a rural tertiary hospital in Nigeria, within a 5 year period.
Methods: Wound swabs collected from 156 out-patients and 353 in-patients were, cultured and microbial isolates identified
using standard methods. Antibiotic susceptibility testing was done on bacterial isolates.
Results: The prevalence of wound infection in 2006, 2007, 2008, 2009 and 2010 was 71.4%, 76.2%, 74.5%, 61.5%, and
67.0% respectively.  The overall prevalence of  wound infection was 70.1%. In all the years studied, out-patients had a higher
prevalence of  wound infection, but this was significant in 2007, 2009, and 2010 only. Staphylococcus aureus was the most
prevalent pathogen in both in- and out - patients with the exception of 2009 where both Staphylococcus aureus and Pseudomonas
aeruginosa had the same prevalence (24.4%) among in - patients. The flouroquinolones were the most potent antimicrobial
agents against bacterial isolates from both in – and out –patients.
Conclusions: Staphylococcus aureus was the most predominant etiologic agent of wound infection among in and out
patients. A generally higher resistance pattern was observed among nosocomial bacterial pathogens. Prudent use of  antibiotics
is recommended.
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The unbroken skin is the first line of defense and a
barrier against microbial invasion. It serves as host
to a variable number of transient or contaminating
bacteria. Although its low surface pH, sebaceous fluid,
and fatty acids produced inhibits the colonization
and growth of pathogenic organisms1, exposure of
subcutaneous tissue following loss of skin integrity
provides a moist, warm, and nutritious environment
that is conducive for microbial colonization and
proliferation2. The progression of a wound to an
infected state involves a multitude of microbial and
host factors such as type, site, size and depth of the
wound, the extent of non-viable exogenous
contamination, the level of blood perfusion to the
wound, the general health and immune status of the
host, the microbial and combined level of virulence
expressed by the types of micro-organisms
involved2.
Nosocomial wound infections are a serious
health concern. Infection of wound following
surgery has been common in spite of recent
advances made in asepsis. It is an important cause
of  illness, resulting in prolonged hospital stay,
increased trauma care, and treatment cost. It also
causes a significant strain on the surgeon and nursing
staff3, making wound management practices much
more demanding. Repeat admissions following
discharge have been noted to be more frequent
among patients who had post operative wound
infection than those without one3. Nosocomial
wound infections have also been reported to be
frequent in non-surgical ward of most hospitals4.
The etiology of  wound infection differs
from country to country and from hospital to
hospital even within the same region5. Control of
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wound infections has been very challenging due to
widespread bacterial resistance to antibiotics and due
to an increasing incidence of infection caused by
methicillin – resistant Staphylococus aureus (MRSA) and
polymicrobic flora6 . Studies have shown that most
hospitals in developing countries especially Africa,
have rudimentary and highly compromised infection
control programmes due to lack of awareness of
the problem, lack of  personnel , poor water supply,
erratic electricity supply, poor laboratory back up and
funding7. These factors are rife in most rural health
care centres in Nigeria, and underscore the need for
this study. Accurate information of  the incidence and
etiology of  infections acquired within a hospital is
essential for articulation of effective preventive
measures8 . Against this background, this study was
aimed at determining the prevalence of  wound
infection and susceptibility profile of associated
aerobic bacteria from patients at a rural tertiary health
care facility in Edo State. Nigeria.
Methods
Study Area
Okada, a rural community is the headquarter of Ovia
Northeast local government area of Edo State,
Nigeria. The local government has an estimated
population of 155 344 persons9. Majority of the
residents of  Okada are farmers with few civil
servants, lecturers, and students making less than 5%
of  the community. Igbinedion University Teaching
Hospital is the only tertiary health care provider in
Okada. Some people from neighboring rural
communities (villages) also attend the Hospital.
Study population
A total of 509 (190 females and 319 males) with
overt signs and symptoms of wound infection in
the out - patient and in - patient departments of
Igbinedion University Teaching  Hospital were
recruited for this study. The age range of  the study
population was 4 years - 73 years. Verbal informed
consent was obtained from all participating subjects
or their parents/guardian in case of children prior
to specimen collection. The study was approved by
the Ethical Committee of the Igbinedion University
Teaching Hospital, Okada, Nigeria.
Collection and processing of specimen
A pair of wound swab was collected from each
patient and transported to the laboratory for analysis
within one hour. One of  the wound swabs was used
to make film and stained by gram’s stain. The second
swab was cultured onto blood, MacConkey and
Sabouraund agar, and incubated for 24 to 48 hours
at 37°C. Candidiasis was diagnosed by the presence
of yeast-like cells as well as identification of isolates
from culture. Bacterial isolates were identified using
standard laboratory techniques10. All yeast isolates
were inoculated on CHROMAgar Candida™ and
incubated for 48hours at 37oC. The colour produced
by each colony was used to identify the yeast.
Antibiotic susceptibility test for bacterial isolates was
performed using the BSAC method11.
Statistical analysis
The data obtained were analyzed using Chi-square
or Fischer’s exact test as appropriate and odd ratio
analysis using the statistical software INSTAT®.
Results
A statistically significant difference was observed
between the prevalence of wound infections among
in-patients (64.6%). and out-patients (82.7%) (p <
0.0001). The prevalence of wound infection among
out-patients from 2006 to 2010 did not differ
significantly (p>0.05). A similar picture was observed
among in-patients. However, out - patients had
significantly higher prevalence than in-patients in the
year 2007, 2009 and 2010 as indicated in table 1.
Age and gender did not affect the
prevalence of wound infection among in- and out-
patients as shown in table 2.
Staphylococcus aureus (40.3%) was the most
predominant isolate followed by Pseudomonas
aeruginosa (23.9%), while Citrobacter sp was the least
(H = 0.5%). Candida albicans was the only fungi
isolated with a prevalence of H=1.0%. In all the
years – from 2006 to 2010, Staphylococcus aureus was
the most prevalent pathogen in both in- and out-
patients with the exception of 2009 where both
Staphylococus aureus and Pseudomonas aeruginosa had the
same prevalence among in - patients (24.4%) as
shown in table 3.
The flouroquinolones were the most active
antibacterial agents against bacterial isolates from in
and out patients studied. A generally higher resistance
pattern was observed among nosocomial bacterial
pathogens as indicated in tables 4 and 5.
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Table 1:   Yearly prevalence of  wound infection
N - number tested; OR - odd ratio; CI - confidence interval; pvalue (Out – Patients) = 0.427; p value (In-
Patients) = 0.104
Table 2: Effect of  gender and age on prevalence of  wound infection
Characteristics Out - patients In - patients
N N Pos (%) N N Pos (%)            P value
Male 52 41(78.8) 138 83 (60.1)               0.017         
Female 104 88 (84.6) 215 145 (67.4) 0.001       
Age (years)
5 - 14                          12 12(100)                        31 24(77.4) 0.163        
15 - 24                          25 19(76.0) 56 35(62.5) 0.310
25 - 35                          20 15(75.0) 49 27(55.1) 0.176
35 - 44                          33 23(69.7) 61 30(49.2) 0.081
45 - 54                          21 18(85.7) 53 40(75.5) 0.532
55 - 64                          17 15(88.2) 79           51(64.6) 0.082
≥ 65                              28 27 (96.4) 24 21(87.5) 0.324
N-number tested; Out-patients (Male v Female): p = 0.378; In -patient: (Male v  Female): p= 0.199; Out -
patients (Age): p = 0.156; In-patients (Age): p= 0.28
Table 3: Distribution of  micro-organism from infected wound
Year Out - patients                          In - OR 95%CI          P value
N       Number 
infected 
(%)           
patients 
N       
Number 
infected 
(%)           
2006 20 17 (85.0) 64 43 (67.2)             2.767     0.7290,  0.506    0.1614           
2007 37 33 (89.1)                       85 60 (70.5)            3.438     1.102, 10.727      0.0361            
2008 31 25 (80.6)                67 48 (71.6)             1.649     0.5843, 4.655      0.4566            
2009 46 35 (76.1)                71 37 (52.1)              2.924     1.285, 6.654       0.0115
2010 22 19 (86.4) 66 40 (60.1)             4.117    1.106, 15.322      0.0333   
Total 156 129 (82.7)                 353 228 (64.6) 2.619   1.639, 4.186      <0.0001
Mixed 
infection
2006-2010                                     12 (9.3) 28(12.3)                 0.7326  0.3588, 1.496      0.4855
Organism Number
(%)































Escherichia coli 54(13.5) 3(15.0) 6(12.0) 9(26.5) 9(14.1) 1(3.5) 9(16.7) 1(2.4) 6(13.3) 1(4.8) 9(20.5)
Klebsiella spp 35(8.7) 1(5.0) 1(2.0) 4(11.7) 7(10.9) 1(3.5) 4(7.4) 3(7.3) 9(20.0) 2(9.6) 3(6.8)
Proteus spp 36(8.9) 0(0.0) 1(2.0) 3(8.8) 5(7.8) 4(14.2) 6(11.1) 0(0.0) 5(11.1) 3(14.3) 9(20.5)
Pseudomonas
aeruginosa
96(23.9) 5(25.0) 12(24.0) 6(17.6) 16 (25.0) 7(25.0) 15(27.8) 11(26.8) 11(24.4) 4(19.0) 9(20.5)
Citrobacter spp 2(0.5) 0(0.0) 0(0.0) 0(0.0) 0(0.0) 0(0.0) 0(0.0) 0(0.0) 0(0.0) 0(0.0) 0(0.0)
Staphylococcus
aureus
162(40.3) 10(50.0) 29(58.0) 10(29.4) 24(37.5) 14(50.0) 20(37.0) 22(53.6) 11(24.4) 8(38.1) 14(31.8)
Streptococcus
pyogenes
5(1.2) 0(0.0) 0(0.0) 0(0.0) 2(3.1) 1(3.5) 0(0.0) 0(0.0) 2(4.5) 0(0.0) 0(0.0)
Enterococcus
feacalis
7(1.7) 0(0.0) 1(2.0) 1(2.9) 0(0.0) 0(0.0) 0(0.0) 1(2.4) 1(2.2) 3(14.3) 0(0.0)
Candida
albicans
4(4) 1(5.0) 0(0.0) 1(2.9) 1(1.6) 0(0.0) 0(0.0) 1(2.4) 0(0.0) 0(0.0) 0(0.0)
Total 20 50 34 64 28 54 41 45 21 44
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Table 4: Susceptibility profile of  bacterial isolates from in patients
CIP - Ciprofloxacin; OFX - Ofloxacin;  CAZ- Ceftriaxone; CRO- Ceftazidime; GEN- Gentamicin;  AU-
Amoxicillin- Cluvalanate; SXT- Sulfamethoxazole; TE- Tetracycline; AM-Ampxycillin; CHL- Chloramphenicol
Bacterial agents (n) CIP OFX CAZ CRO GEN AU SXT TE AM CHL
(10) (%) (10) (%) (30) (%) (25) (%) (10) (%) (30) (%) (30) (%) (10) (%) (30) (%) (30) (%)
Escherichia coli (39) 30(76.9)     32(82.5) 28(71.8) 27(69.2) 19 (48.7) 21(53. 8) 0(0.0) 0(0.0) 0(0.0) 0(0.0)
Klebsiella spp (24) 19(79.1) 19(79.1) 17(70.8) 14(58.3) 10(41.6) 14(58.3) 0(0.0) 0(0.0) 0(0.0) 0(0.0)
Proteus spp (26) 20(76.9) 21(80.7) 18(69.2) 18(69.2) 7(26.9) 10(38.5) 0(0.0) 0(0.0) 0(0.0) 0(0.0)
Pseudomonas aeruginosa (63) 51(80.9) 53(84.1) 50(79.3) 52(82.5) 29(46.0) 36(57.1) 0(0.0) 0(0.0) 0(0.0) 0(0.0)
Staphylococcus aureus (98) 72(73.5) 80(81.6) 75(76.5) 70(71.4) 48(48.8) 57(58.2) 0(0.0) 0(0.0) 0(0.0) 0(0.0)
Streptococcus pyogenes (4) 4(100.0) 4(100.0) 4(100.0) 2(50.0) 2(50.0) 3(75.0) 0(0.0) 0(0.0) 0(0.0) 0(0.0)
Enterococcus feacalis (2) 2(100.0) 2(100.0) 2 (100.0) 1(50.0) 1(50.0) 2(100.0) 0(0.0) 0(0.0) 0(0.0) 0(0.0)
Bacterial agents (n) CIP OFX CAZ CRO GEN AU SXT TE AM CHL
(10) (%) (10) (%) (30) (%) (25) (%) (10) (%) (30) (%) (30) (%) (10) (%) (30) (%) (30) (%)
Escherichia coli (15) 14(93.3)     15(100.0) 13(86.6) 13(86.6) 10(66.6) 11(73.3) 0(0.0) 0(0.0) 0(0.0) 0(0.0)
Klebsiella spp (11) 9(81.8) 9(81.8) 9(81.8) 7(63.6) 5(45.5) 7(63.6) 0(0.0) 0(0.0) 0(0.0) 0(0.0)
Proteus spp (10) 9(90.0) 8(80.0) 8(80.0) 7(70.0) 4(40.0) 6(60.0)        0(0.0) 0(0.0) 0(0.0) 0(0.0)
Pseudomonas aeruginosa (33) 26(78.8) 28(84.8) 27(81.8) 25(75.7) 20(60.6) 22(66.6)      0(0.0) 0(0.0) 0(0.0) 0(0.0)
Citrobacter spp (2) 2(100.0) 2(100.0) 2(100.0) 2(100.0) 2(100.0) 2(100.0) 0(0.0) 0(0.0) 0(0.0) 0(0.0)
Staphylococcus aureus (64) 55(65.9) 60(93.7) 58(90.6) 56(87.5) 41(64.1) 53(82.8) 0(0.0) 0(0.0) 0(0.0) 0(0.0)
Streptococcus pyogenes (1) 1(100.0) 1(100.0)        1(100.0)        1(100.0)        1(100.0)        1(100.0)        0(0.0) 0(0.0) 0(0.0) 0(0.0)
Enterococcus feacalis (5) 4(80.0) 5(100.0) 4(80.0) 4(80.0) 2(40.0) 4(80.0)      0(0.0) 0(0.0) 0(0.0) 0(0.0)
Table 5: Susceptibility profile of  bacterial isolates from out patients
CIP - Ciprofloxacin; OFX - Ofloxacin;  CAZ- Ceftriaxone; CRO- Ceftazidime; GEN- Gentamicin;  AU-
Amoxicillin- Cluvalanate; SXT- Sulfamethoxazole; TE- Tetracycline; AM-Ampxycillin; CHL- Chloramphenicol
Discussion
Epidemiological surveillance of  infection is
indispensable for effective management of diseases,
and the creation and implementation of control
measures. This is particularly important in resources
poor settings in Africa, were data on disease
prevalence is sparsely documented, and prevailing
factors such as poor access to running water, poor
hygiene, poverty and illiteracy often serves as catalyst
for spread of  diseases. Although a number of  studies
have been conducted on wound infections in some
hospital and clinics in Nigeria, to the best of our
knowledge, none has focused on its prevalence and
etiology among in and out patients in a rural health
care facility.
The overall prevalence of wound infection
in this study was 70.1%. This agrees with a previous
report12, but is at variance with others4, 13, 14. The
etiology of  wound infection differs from country
to country and from hospital to hospital even within
the same region5.
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This coupled with the differences in nature and site
of wound infection in study centers may account
for the observed variation. In all the years studied,
no statistically significant difference was recorded in
prevalence of wound infection among in- and out-
patients. Generally, a significantly higher prevalence
of  wound infection was observed among out-
patients (82.7%) than in - patients (64.6%) during
the years of  this study. Okada and other neighboring
communities are strictly rural settings with inhabitants
being largely farmers. High rate of  occupational
related injuries, poor hygiene and accessibility to
health care facility may be responsible for the
observed trend. Age and gender did not significantly
affect the prevalence of  wound infection in this study.
These have been previously confirmed in two
separate Nigerian studies14, 15. In all the years studied,
Staphylococcus aureus was the most prevalent in both
in- and out-patients with the exception of 2009
where both Staphylococus aureus and Pseudomonas.
aeruginosa had the same prevalence among in - patients
(24.4%). The leading role of Staphylococus aureus and
Pseudomonas aeruginosa in wound infection has been
severally documented14, 16. Candida albicans was the
only fungal specie isolated from this study.
Generally among bacterial isolates from in
and out patients, the flouroquinolones (Ciprofloxacin
and Ofloxacin) were the most potent antimicrobial
agents observed. Irrespective of  source,
Sulfamethoxazole –Trimethoprim, Tetracycline,
Amoxicillin and Chloramphenicol were found to
have no activity on bacterial isolates. Prescription of
antibiotics without laboratory guidance as well as
over the counter sales of antibiotics without
prescription have been noted to be rife in Nigeria17.
These antibiotics with no activity against bacterial
isolates are cheap to procure in Nigeria. This coupled
with the ease of accessibility encourages their misuse
and overuse, leading to the development of bacterial
resistance over time. Antimicrobial susceptibility
testing of bacterial isolates in five year period under
study revealed that nosocomial pathogens were
generally more resistant to antibiotics as compared
to those from out - patients. Selective pressure due
to repeated use of disinfectants in hospital settings
may account for this observation.
Conclusion
An overall prevalence of 70.1% of wound infection
was observed in this study, with prevalence being
significantly higher generally among out-patients. With
the exception of 2009, where the prevalence of
Staphylococus aureus and Pseudomonas aeruginosa were the
same (24.4%), among in - patients, Staphylococcus aureus
was the most predominant etiologic agent of wound
infection observed among in- and out- patients. The
flouroquinolones were the most active antimicrobial
agents observed among bacterial isolates from in
and out patients studied. However a generally higher
antimicrobial resistance pattern was observed among
nosocomial pathogens. Prudent use of  antibiotics is
advocated.
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